Atomistry » Iron » PDB 8ca4-8csp » 8cjk
Atomistry »
  Iron »
    PDB 8ca4-8csp »
      8cjk »

Iron in PDB 8cjk: Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-098

Enzymatic activity of Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-098

All present enzymatic activity of Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-098:
1.14.16.4;

Protein crystallography data

The structure of Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-098, PDB code: 8cjk was solved by A.Schuetz, K.Mallow, M.Nazare, E.Specker, U.Heinemann, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 41.15 / 1.46
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 46.96, 57.875, 59.054, 90, 97.74, 90
R / Rfree (%) 15.5 / 18.4

Iron Binding Sites:

The binding sites of Iron atom in the Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-098 (pdb code 8cjk). This binding sites where shown within 5.0 Angstroms radius around Iron atom.
In total only one binding site of Iron was determined in the Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-098, PDB code: 8cjk:

Iron binding site 1 out of 1 in 8cjk

Go back to Iron Binding Sites List in 8cjk
Iron binding site 1 out of 1 in the Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-098


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 1 of Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-098 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Fe501

b:11.7
occ:1.00
NE2 A:HIS277 2.1 12.6 1.0
NE2 A:HIS272 2.1 11.8 1.0
NAQ A:UVU502 2.1 14.8 1.0
OE2 A:GLU317 2.2 13.5 1.0
O A:HOH635 2.2 14.4 1.0
OE1 A:GLU317 2.3 14.6 1.0
CD A:GLU317 2.6 14.6 1.0
CE1 A:HIS272 3.0 12.8 1.0
CE1 A:HIS277 3.0 12.1 1.0
CBD A:UVU502 3.1 16.2 1.0
CD2 A:HIS277 3.1 11.1 1.0
CD2 A:HIS272 3.1 11.9 1.0
CAX A:UVU502 3.2 15.1 1.0
CAO A:UVU502 3.5 15.0 1.0
SAU A:UVU502 3.8 17.5 1.0
CG A:GLU317 4.1 14.8 1.0
ND1 A:HIS272 4.2 14.0 1.0
ND1 A:HIS277 4.2 13.4 1.0
NBJ A:UVU502 4.2 16.8 1.0
CG A:HIS277 4.2 13.9 1.0
CG A:HIS272 4.2 11.6 1.0
OE1 A:GLU273 4.3 16.4 1.0
CAM A:UVU502 4.3 16.3 1.0
OH A:TYR312 4.4 14.1 1.0
CZ A:PHE250 4.5 29.4 1.0
CB A:ALA332 4.6 12.9 1.0
O A:HOH828 4.7 53.0 1.0
O A:HOH733 4.8 19.6 1.0
C8 A:UVU502 5.0 15.2 1.0

Reference:

E.Specker, R.Wesolowski, A.Schutz, S.Matthes, K.Mallow, M.Wasinska-Kalwa, L.Winkler, A.Oder, N.Alenina, D.Pleimes, J.P.Von Kries, U.Heinemann, M.Bader, M.Nazare. Structure-Based Design of Xanthine-Imidazopyridines and -Imidazothiazoles As Highly Potent and in Vivo Efficacious Tryptophan Hydroxylase Inhibitors. J.Med.Chem. V. 66 14866 2023.
ISSN: ISSN 0022-2623
PubMed: 37905925
DOI: 10.1021/ACS.JMEDCHEM.3C01454
Page generated: Fri Aug 9 21:43:45 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy